Latest news and views from PBD Biotech about the detection, identification and eradication of tuberculosis and related mycobacterial diseases.
Actiphage is the only test in development for subclinical tuberculosis that directly detects mycobacteria in the blood, it has been revealed by the TAG pipeline report
Actiphage is the only test in development for subclinical tuberculosis that directly detects mycobacteria in the blood, it has been...
The Global Plan to End TB is a costed public health plan. It aims to cut deaths by 90% in 8 years. A key recommendation of the report is to universally replace sputum microscopy with rapid molecular diagnostics.
The Global Plan to End TB is a costed public health plan. It aims to cut deaths by 90% in...
Human tuberculosis is second only to Covid as the world’s most fatal infectious disease. PBD Biotech has developed a diagnostic with potential to revolutionise management of TB.
Human tuberculosis is second only to Covid as the world’s most fatal infectious disease. PBD Biotech has developed a diagnostic...
Ease of use at the point of need is vital for the roll out of a diagnostic, so PBD Biotech, developers of Actiphage - a rapid blood test for early-stage tuberculosis - is partnering with the Rapid Research in Diagnostics...
Ease of use at the point of need is vital for the roll out of a diagnostic, so PBD Biotech,...
New Chief Operating Officer brings experience of tuberculosis vaccine and precision medicine.
New Chief Operating Officer brings experience of tuberculosis vaccine and precision medicine.
A study presented at ICP 2022 has shown that the blood test Actiphage is able to distinguish between goats that are naturally infected and those vaccinated against Mycobacterium avium subspecies paratuberculosis (MAP), the pathogen that causes Johne’s Disease, supporting the...
A study presented at ICP 2022 has shown that the blood test Actiphage is able to distinguish between goats that...
This is the first time Actiphage has been used to detect MAP in a human blood sample and also to identify a live infection in a vaccinated goat.
This is the first time Actiphage has been used to detect MAP in a human blood sample and also to...
Results presented at ICP (12-16th June) from first study in North American bison, shows capacity of Actiphage to sub-type mycobacteria in blood.
Results presented at ICP (12-16th June) from first study in North American bison, shows capacity of Actiphage to sub-type mycobacteria...
The findings are a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of mycobacteria in the blood is an indication that the animal is infected and has the potential to develop disease.
The findings are a real breakthrough for animal diagnosis as it provides clinical evidence that detection of low levels of...
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live bacteria can be detected in the blood of people with incipient TB infection.
A clinical trial of Actiphage, a promising new diagnostic for tuberculosis infection, has shown for the first time that live...
A new rapid testing service from PBD Biotech will enable farmers to find out in days if a bulk milk or blood sample contains MAP, the bacteria that causes Johne's Disease an economically devastating disease.
A new rapid testing service from PBD Biotech will enable farmers to find out in days if a bulk milk...
Sub-Saharan Africa is devastated by TB disease. Zambia, has a high TB/HIV burden – 59,000 people developed TB in 2020 and 15,000 died. There is a critical need for a non-sputum based rapid test for diagnosing TB disease.
Sub-Saharan Africa is devastated by TB disease. Zambia, has a high TB/HIV burden – 59,000 people developed TB in 2020...
